Pharmacology of pain control Flashcards

1
Q

Acute pain

A

Minutes, hours, days

Well defined onset

Associated with objective and subjective physical signs

Hyperactivity of the autonomic nervous system

Responds well to analgesia and treatment of underlying problem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Chronic pain

A

Weeks, months

Associated with significant changes in lifestyle, function and personality

More challenging management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Types of nociceptive pain

A

Somatic

Visceral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Somatic pain

A

Causes: activation of nociceptors in skin, muscle and bone

Symptoms: localised, aching, throbbing, gnawing

Examples: bone metastasis, tumour invasion into soft tissue, muscle spasticity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Visceral pain

A

Causes: activation of nociceptors from stretching, distension or inflammation

Symptoms: poorly localised, deep aching, cramping, pressure, referred pain

Examples: bowel obstruction, pancreatic cancer, liver metastases, capsular pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Neuropathic pain

A

Causes: direct damage to PNS or CNS

Symptoms: burning, shooting, stabbing, electric shock, altered sensation

Examples: damage to nerve plexus, post hepatic neuralgia, spinal cord compression, diabetic neuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Ascending pain pathways

A

Nociceptors

C fibres and A-delta fibres

Spinal ganglia

Dorsal horn

Lateral spinothalamic tract

Pain perception point

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Descending

A

Brain (cortex and thalamus)

Periaqueductal grey

Rostral ventral medulla

Dorsal root ganglion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

WHO analgesic ladder

A

Step1: non-opiod analgesic + adjuvant

Step 2: weak opioid + non-opioid + adjuvant

Step 3: Strong opioid + non-opioid + adjuvant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Non-opioid

A

Paracetamol

Aspirin

NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Weak opioid

A

Tramadol

Codeine

Dihydrocodeine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Strong opioid

A

Morphine

Oxycodone

Fentanyl

Diamorphine

Alfetanil

Hydromorphone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Types of adjuvants

A

Pharmacological

Non-pharmacological

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pharmacological adjuvants

A

Corticosteroids

Antidepressants

Antiepileptics

Anti-muscarinics

Benzodiazepines

Bisphosphonates

Ketamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Non-pharmacological adjuvants

A

TENS

Acupuncture

Massage

Heat

Psychological support and relaxation

Radiotherapy

Interventional techniques

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Opioid receptors

A

G protein coupled receptors

3 main subtypes (Mu, kappa, delta)

Locations

  • CNS (cortex, thalamus, hypothalamus, PAG, RVM)
  • other (enteric plexus of gut, peripheral sensory afferent nerves, dorsal root cells, immune cells)
17
Q

Mu opioid receptors

A

Endogenous opioid
- beta- endorphins

Drug effects of receptor binding
- analgesia, respiratory depression, euphoria, miosis, constipation

18
Q

Kappa opioid receptor

A

Endogenous opioid
- dynorphins

Drug effects of receptor binding
- analgesia, dysphoria, miosis, diuresis

19
Q

Delta opioid receptor

A

Endogenous opioid
- enkephalins

Drug effects of receptor binding
- analgesia, respiratory depression

20
Q

Opioid effects: analgesia

A

Anti-nociception and effect on emotional response

Direct inhibition of ascending transmission of nociceptive information from the spinal cord dorsal horn

Activation of descedning pain control circuits from the midbrain to the dorsal horn

21
Q

Opioid effects: psychotropic

A

Anxiolysis and euphoria may also help with analgesic properties

22
Q

Opioid effects: respiratory depression

A

Direct effect on respiratory centre in medulla

Example: oramorph for SOB in patients with ed stage COPD

23
Q

Opioid effects: suppression of cough reflex

A

Example: codeine linctus for cough

24
Q

Opioid effects: constipation

A

Delayed gastric emptying and inhibition of peristalsis

Example: codeine for high output stoma

25
Opioid toxicity: symptoms
Drowsiness Myoclonic jerks Pinpoint pupils (miosis) Respiratory depression Agitation Confusion Vivid dreams Hallucinations
26
Opioid toxicity: management
Mild-moderate - reduce or stop opioid - check renal and hepatic function - ensure adequate hydration Severe toxicity - RR <8, decreased O2 sats, unresponsive - naloxone
27
Codeine
Action: Mu receptor Dose: 15-60mg PO QDS (240mg/24 hrs) Major side effects: constipation Morphine equivalence: ÷10
28
Dihydrocodeine
Action: Mu receptor Dose: 15-60mg PO QDS (240mg/25 hrs) Major side effects: constipation Morphine equivalence: ÷10
29
Tramadol
Action: Mu receptor monoaminergic Dose: 50-100mg PO QDS (400mg/24 hrs) Major side effects: N&V, sedation Cautions: elderly, MAOIs, seizures Morphine equivalence: ÷5-10
30
Morphine pharmacology
Mu and kappa receptor agonist Good oral absorption Metabolised in the liver Excreted in the urine Immediate release preparations - oramorph - sevredol Modified release preparations - MST - zomorph
31
Oxycodone
Semi-synthetic opioid Full opioid agonist Metabolised by the liver Given orally Immediate release and modified release preparations
32
Hydromorphone
Similar action to morphine through more selective mu-receptor agonism Metabolised in the liver Can be used in caution in patients with mild to moderate renal impairment Given orally Immediate and modified release preparations
33
Fentanyl
High potent, only consider in patients tolerant to opioids Patches - not suitable with unstable/ rapidly escalating pain - depot will remain in skin for 24hrs post removal Lozenges - rapid onset of action - shorter duration of effect
34
Alfentanil
Third line opioid used with specialist advice Very potent, short acting Synthetic derivative of fentanyl Metabolised in the liver, inactive metabolites Opioid of choice when eGFR <30ml/min